134 related articles for article (PubMed ID: 20812464)
1. Low-income Medicare beneficiaries and their experiences with the part D prescription drug benefit.
Rudolph NV; Montgomery MA
Inquiry; 2010; 47(2):162-72. PubMed ID: 20812464
[TBL] [Abstract][Full Text] [Related]
2. Associations Between Annual Medicare Part D Low-Income Subsidy Loss and Prescription Drug Spending and Use.
Fung V; Price M; Cheng D; Patel TA; Yang Z; Hsu J; Alegria M; Newhouse JP
JAMA Health Forum; 2024 Feb; 5(2):e235152. PubMed ID: 38306091
[TBL] [Abstract][Full Text] [Related]
3. Cognition and take-up of subsidized drug benefits by Medicare beneficiaries.
Kuye IO; Frank RG; McWilliams JM
JAMA Intern Med; 2013 Jun; 173(12):1100-7. PubMed ID: 23649604
[TBL] [Abstract][Full Text] [Related]
4. Consequences of forgoing prescription drug subsidies among low-income Medicare beneficiaries with diabetes.
Glynn A; Hernandez I; Roberts ET
Health Serv Res; 2022 Oct; 57(5):1136-1144. PubMed ID: 35430735
[TBL] [Abstract][Full Text] [Related]
5. Impact of Part D low-income subsidies on medication patterns for Medicare beneficiaries with diabetes.
Stuart B; Yin X; Davidoff A; Simoni-Wastila L; Zuckerman I; Shoemaker JS; Doshi J
Med Care; 2012 Nov; 50(11):913-9. PubMed ID: 23047779
[TBL] [Abstract][Full Text] [Related]
6. The relationship between the low-income subsidy and cost-related nonadherence to drug therapies in Medicare Part D.
Wei II; Lloyd JT; Shrank WH
J Am Geriatr Soc; 2013 Aug; 61(8):1315-23. PubMed ID: 23889465
[TBL] [Abstract][Full Text] [Related]
7. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.
Yala SM; Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF
BMC Health Serv Res; 2014 Dec; 14():665. PubMed ID: 25526892
[TBL] [Abstract][Full Text] [Related]
8. Medicare Part D low-income subsidies expanded in January 2024, but more needs to be done to ensure that eligible beneficiaries enroll.
Loh FE; Stuart BC; Hunt RJ; Negari M
J Manag Care Spec Pharm; 2024 Mar; 30(3):279-289. PubMed ID: 38324387
[TBL] [Abstract][Full Text] [Related]
9. Sociodemographic and spending characteristics of Medicare beneficiaries taking prescription drugs subject to price negotiations.
Odouard IC; Anderson GF; Alexander GC; Ballreich J
J Manag Care Spec Pharm; 2024 Mar; 30(3):269-278. PubMed ID: 38140901
[TBL] [Abstract][Full Text] [Related]
10. Potential savings associated with drug substitution in Medicare Part D: the Translating Research into Action for Diabetes (TRIAD) study.
Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF; Fu J; Simien L; Tseng CW
J Gen Intern Med; 2014 Jan; 29(1):230-6. PubMed ID: 23975059
[TBL] [Abstract][Full Text] [Related]
11. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
Blumberg DM; Prager AJ; Liebmann JM
JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
[TBL] [Abstract][Full Text] [Related]
12. Association of Medicare Part D low-income cost subsidy program enrollment with increased fill adherence to clopidogrel after coronary stent placement.
Duru OK; Edgington S; Mangione C; Turk N; Tseng CH; Kimbro L; Ettner S
Pharmacotherapy; 2014 Dec; 34(12):1230-8. PubMed ID: 25314343
[TBL] [Abstract][Full Text] [Related]
13. Using matched survey and administrative data to estimate eligibility for the Medicare Part D low-income subsidy program.
Meijer E; Karoly LA; Michaud PC
Soc Secur Bull; 2010; 70(2):63-82. PubMed ID: 20560303
[TBL] [Abstract][Full Text] [Related]
14. Association of low-income subsidy, medicaid dual eligibility, and disability status with high-risk medication use among Medicare Part D beneficiaries.
Chinthammit C; Bhattacharjee S; Lo-Ciganic WH; Axon DR; Slack M; Bentley JP; Warholak TL
Res Social Adm Pharm; 2022 Apr; 18(4):2634-2642. PubMed ID: 34006485
[TBL] [Abstract][Full Text] [Related]
15. How Low-Income Subsidy Recipients Respond to Medicare Part D Cost Sharing.
Stuart B; Hendrick FB; Xu J; Dougherty JS
Health Serv Res; 2017 Jun; 52(3):1185-1206. PubMed ID: 27324201
[TBL] [Abstract][Full Text] [Related]
16. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
Thomas CP; Sussman J; ;
Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
[TBL] [Abstract][Full Text] [Related]
17. Association of high cost sharing and targeted therapy initiation among elderly Medicare patients with metastatic renal cell carcinoma.
Li P; Wong YN; Jahnke J; Pettit AR; Doshi JA
Cancer Med; 2018 Jan; 7(1):75-86. PubMed ID: 29195016
[TBL] [Abstract][Full Text] [Related]
18. Use and Spending for Biologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis Among US Medicare Beneficiaries.
Yazdany J; Tonner C; Schmajuk G
Arthritis Care Res (Hoboken); 2015 Sep; 67(9):1210-1218. PubMed ID: 25776035
[TBL] [Abstract][Full Text] [Related]
19. Do Restrictions on Antipsychotic Use Differ Between Medicare Part D Stand-Alone Versus Medicare Advantage Plans?
Chou J; Brandt NJ; Loh FE; Stuart B
Consult Pharm; 2017 Feb; 32(2):109-118. PubMed ID: 28569663
[TBL] [Abstract][Full Text] [Related]
20. Out-of-pocket burden of health care spending and the adequacy of the Medicare Part D low-income subsidy.
Briesacher BA; Ross-Degnan D; Wagner AK; Fouayzi H; Zhang F; Gurwitz JH; Soumerai SB
Med Care; 2010 Jun; 48(6):503-9. PubMed ID: 20473197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
